Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2025-12-24 @ 7:35 PM
NCT ID:
NCT02265003
Eligibility Criteria:
Groups 1-3:
Inclusion Criteria:
* healthy subjects
* informed consent
Exclusion Criteria:
* hypertension (blood pressure ≥140/90 mmHg),
* hypercholesterolemia (LDL ≥250 mg/dl, HDL ≤45 mg/dl),
* diabetes mellitus (fasting plasma glucose ≥128 mg/dl)
* acute inflammation (CRP \>0.5 mg/dl)
* malignant diseases
* heart failure (NYHA III-IV)
* arrhythmia of high degree
* acute or terminated kidney disease
* cardiovascular diseases ( cardiac artery disease, peripheral vascular disease and cerebrovascular diseases)
* anemia
* pregnancy
Group 4 :
Inclusion Criteria:
* angiographical signs of apparent atherosclerosis (cardiac artery disease or peripheral vascular disease or degenerative valvular heart disease)
* informed consent
Exclusion Criteria:
* Hypertension (blood pressure ≥140/90 mmHg),
* Hypercholesterolemia (LDL ≥250 mg/dl, HDL ≤45 mg/dl),
* Diabetes mellitus (fasting plasma glucose ≥128 mg/dl)
* acute inflammation (CRP \>0.5 mg/dl)
* malignant diseases
* heart failure (NYHA III-IV)
* arrhythmia of high degree
* acute or terminated kidney disease
* cardiovascular diseases ( cardiac artery disease, peripheral vascular disease and cerebrovascular diseases)
* anemia
* pregnancy
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02265003
Study Brief:
Protocol Section:
NCT02265003